{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:41:30Z","timestamp":1790642490083,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Associazione Italiana Rene Policistico"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40620-021-01131-w","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T11:03:24Z","timestamp":1628247804000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expanding the variability of the ADPKD-GANAB clinical phenotype in\u00a0a family of Italian ancestry"],"prefix":"10.1093","volume":"35","author":[{"given":"Elisa","family":"Delbarba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Econimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Dordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Savoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Alberici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Izzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"1131_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Torres VE, Harris PH (2018) Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol 29:13\u201323","journal-title":"J Am Soc Nephrol"},{"key":"1131_CR2","first-page":"477","volume":"79","author":"F Davies","year":"1991","unstructured":"Davies F, Coles GA, Harper PS, William AJ, Evans C, Cochlin D (1991) Polycystic kidney disease re-evaluated: a population-based study. Q J Med 79:477\u2013485","journal-title":"Q J Med"},{"key":"1131_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76:149\u2013168","journal-title":"Kidney Int"},{"issue":"1","key":"1131_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE (2018) Polycystic kidney disease. Nat Rev Dis Primers 4(1):50","journal-title":"Nat Rev Dis Primers"},{"key":"1131_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD (2019) Autosomal dominant polycystic kidney disease. Lancet 393:919\u2013935","journal-title":"Lancet"},{"key":"1131_CR6","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1681\/ASN.2016090938","volume":"28","author":"IA Iliuta","year":"2017","unstructured":"Iliuta IA, Kalatharan V, Wang K et al (2017) Polycystic kidney disease without an apparent family history. J Am Soc Nephrol 28:2768\u20132776","journal-title":"J Am Soc Nephrol"},{"key":"1131_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","volume":"98","author":"B Porath","year":"2016","unstructured":"Porath B, Gainullin V, Cornec-Le Gall E et al (2016) Mutations in GANAB, encoding the glucosidase II alpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:1193\u20131207","journal-title":"Am J Hum Genet"},{"key":"1131_CR8","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1172\/JCI90129","volume":"127","author":"W Besse","year":"2017","unstructured":"Besse W, Dong K, Choi J et al (2017) Isolated polycystic liver disease genes define effectors of polycystin-1 function. J Clin Invest 127:1772\u20131785","journal-title":"J Clin Invest"},{"key":"1131_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/humu.23383","volume":"39","author":"W Besse","year":"2018","unstructured":"Besse W, Choi J, Ahram D et al (2018) A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family. Hum Mutat 39:378\u2013382","journal-title":"Hum Mutat"},{"issue":"1","key":"1131_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ et al (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26(1):160\u2013172","journal-title":"J Am Soc Nephrol"},{"key":"1131_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0272-6386(88)80137-9","volume":"11","author":"VE Torres","year":"1988","unstructured":"Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW (1988) The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11:318\u2013325","journal-title":"Am J Kidney Dis"},{"key":"1131_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2215\/CJN.02830317","volume":"12","author":"BV Reddy","year":"2017","unstructured":"Reddy BV, Chapman AB (2017) A patient with a novel gene mutation leading to autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 12:1695\u20131698","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"1131_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fgene.2019.00044","volume":"2019","author":"E Waldrop","year":"2019","unstructured":"Waldrop E, Al-Obaide MAI, Vasylyeva TL (2019) GANAB and PKD1 variations in a 12 years old female patient with early onset of autosomal dominant polycystic kidney disease. Front Genet 2019(10):44","journal-title":"Front Genet"},{"key":"1131_CR14","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1681\/ASN.2019030298","volume":"30","author":"W Besse","year":"2019","unstructured":"Besse W, Chang AR, Luo JZ et al (2019) ALG9 mutation carriers develop kidney and liver cysts. J Am Soc Nephrol 30:2091\u20132102","journal-title":"J Am Soc Nephrol"},{"key":"1131_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/ajkd.2000.8266","volume":"36","author":"SA Grampsas","year":"2000","unstructured":"Grampsas SA, Chandhoke PS, Fan J et al (2000) Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36:53\u201357","journal-title":"Am J Kidney Dis"},{"key":"1131_CR16","first-page":"615","volume":"84","author":"G Morris-Stiff","year":"1997","unstructured":"Morris-Stiff G, Coles G, Moore R, Jurewicz A, Lord R (1997) Abdominal wall hernia in autosomal dominant polycystic kidney disease. Br J Surg 84:615\u2013617","journal-title":"Br J Surg"},{"key":"1131_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbadis.2011.03.003","volume":"1812","author":"IA Drummond","year":"2011","unstructured":"Drummond IA (2011) Polycystins, focal adhesions and extracellular matrix interactions. Biochim Biophys Acta 1812:1322\u20131326","journal-title":"Biochim Biophys Acta"},{"key":"1131_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1086\/368295","volume":"72","author":"A Li","year":"2003","unstructured":"Li A, Davila S, Laszlo F et al (2003) Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 72:691\u2013703","journal-title":"Am J Hum Genet"},{"issue":"6","key":"1131_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ng1357","volume":"36","author":"S Davila","year":"2004","unstructured":"Davila S, Furu L, Gharavi AG et al (2004) Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 36(6):575\u2013577","journal-title":"Nat Genet"},{"key":"1131_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ng.860","volume":"43","author":"SV Fedeles","year":"2011","unstructured":"Fedeles SV, Tian X, Gallagher AR et al (2011) A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet 43:639\u2013647","journal-title":"Nat Genet"},{"key":"1131_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molmed.2014.01.004","volume":"20","author":"SV Fedeles","year":"2014","unstructured":"Fedeles SV, Gallagher AR, Somlo S (2014) Polycystin-1: a master regulator of intersecting cystic pathways. Trends Mol Med 20:251\u2013260","journal-title":"Trends Mol Med"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-021-01131-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:55:59Z","timestamp":1777564559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/35\/2\/645\/8326108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1007\/s40620-021-01131-w","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Observational clinical studies (case report or case series report) do not require approval by the ethics committee according to the AIFA (Italian Medicines Agency) statement 20-03-2008 published in G.U. n. 76 of 31-3-2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed the informed consent form for genetic testing including the authorization for the processing of clinical and genetic data for research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}